{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Bandaram Pharma Packtech Ltd
Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses
Bandaram Pharma Packtech Ltd experienced a pronounced decline on 4 Dec 2025, marked by exclusive selling activity and a lower circuit scenario. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and a lack of buyer interest.
Why is Bandaram Pharma falling/rising?
On 03-Dec, Bandaram Pharma Packtech Ltd experienced a significant decline in its share price, falling by 9.98% to close at ₹38.50. This sharp drop comes after a period of strong gains, highlighting a sudden shift in market sentiment despite the stock’s robust performance over recent weeks.
How has been the historical performance of Bandaram Pharma?
Bandaram Pharma has shown steady growth in net sales and profit over the past three years, with net sales increasing from 18.73 Cr in Mar'23 to 36.96 Cr in Mar'25, and profit after tax rising from 0.26 Cr to 0.99 Cr. Total assets and liabilities also grew significantly during this period, while cash flow from operating activities remained negative but stable.
Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses
Bandaram Pharma Packtech Ltd has encountered significant selling pressure on 3 December 2025, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company’s shares opened sharply lower and have since traded at the day’s low, signalling distress selling and a challenging market environment.
Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Sharp Decline
Bandaram Pharma Packtech Ltd experienced a significant downturn on 2 December 2025, with the stock plunging by 10.0% in a single trading session. The day was marked by extreme selling pressure, with no buyers recorded, signalling distress selling and a notable shift in market sentiment for the healthcare services company.
Bandaram Pharma Packtech Surges with Unprecedented Buying Interest and Upper Circuit Lock
Bandaram Pharma Packtech Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, signalling a potential multi-day circuit scenario for the healthcare services stock.
Is Bandaram Pharma overvalued or undervalued?
As of November 28, 2025, Bandaram Pharma is considered overvalued with a PE ratio of 216.00 and a valuation grade of attractive, despite strong short-term returns, due to negative year-to-date and one-year performance.
Bandaram Pharma Packtech Surges with Unprecedented Buying Interest, Hits Upper Circuit
Bandaram Pharma Packtech Ltd witnessed extraordinary buying momentum on 28 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock opened sharply higher and maintained its peak price throughout the trading session, signalling robust demand and a potential multi-day circuit scenario.
Bandaram Pharma Packtech Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
Bandaram Pharma Packtech, a player in the healthcare services sector, has experienced a notable shift in market assessment driven by a combination of technical indicators and financial performance metrics. Despite recent price gains, the company’s long-term fundamentals and valuation present a complex picture for investors navigating the evolving healthcare equipment landscape.
Bandaram Pharma Packtech Surges with Unprecedented Buying Interest, Hits Upper Circuit
Bandaram Pharma Packtech Ltd witnessed extraordinary buying momentum on 27 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock outperformed the Sensex by a wide margin, reflecting intense demand and a potential multi-day circuit scenario in the healthcare services sector.
Bandaram Pharma Packtech Q2 FY26: Sharp Revenue Recovery Masks Margin Collapse
Bandaram Pharma Packtech Ltd., a micro-cap player in the recycled paper processing industry with a market capitalisation of ₹33.00 crores, reported a net profit of ₹0.06 crores for Q2 FY26, marking a dramatic 200.00% quarter-on-quarter surge but a concerning 91.04% decline year-on-year. The stock has plummeted 40.58% over the past year, significantly underperforming both the Sensex (+9.00%) and its healthcare services sector peers (-22.18%), reflecting deep-seated investor concerns about operational efficiency and profitability sustainability.
How has been the historical performance of Bandaram Pharma?
Bandaram Pharma has shown steady growth in net sales and profit over the past three years, with net sales increasing from 18.73 Cr in Mar'23 to 36.96 Cr in Mar'25, and profit after tax rising to 0.99 Cr in Mar'25. Despite challenges in cash flow management, the company's overall financial performance reflects a positive trend in sales and profitability.
Why is Bandaram Pharma falling/rising?
As of 14-Nov, Bandaram Pharma Packtech Ltd's stock price is at 25.68, down 7.79% today and 42.16% year-to-date. The stock has significantly underperformed the market, with a high Debt to EBITDA ratio and low investor participation, leading to a strong sell recommendation.
How has been the historical performance of Bandaram Pharma?
Bandaram Pharma has shown steady growth in net sales and profits over the past three years, with net sales increasing from 18.73 Cr in Mar'23 to 36.96 Cr in Mar'25, and profit after tax rising from 0.26 Cr to 0.99 Cr. Total assets and liabilities also grew significantly during this period, while cash flow from operating activities remained negative.
Why is Bandaram Pharma falling/rising?
As of 13-Nov, Bandaram Pharma Packtech Ltd's stock price is at 27.85, having increased by 1.42% recently. Despite short-term gains, the stock has underperformed over the long term, with a year-to-date decline of 37.27%, and faces challenges due to reduced investor participation and sector downturns.
Why is Bandaram Pharma falling/rising?
As of 06-Nov, Bandaram Pharma Packtech Ltd's stock price has risen to Rs 26.65, up 9.04%, with strong short-term performance despite a significant year-to-date decline of 39.98%. Increased investor interest is noted, but long-term challenges remain due to sector declines.
Bandaram Pharma Packtech Hits New 52-Week Low at Rs. 23
Bandaram Pharma Packtech has reached a new 52-week low, reflecting a significant decline in its stock performance. The company is trading below key moving averages and has experienced a substantial year-over-year drop. Financial metrics indicate challenges in its long-term strength amid broader market trends.
Why is Bandaram Pharma falling/rising?
As of 29-Oct, Bandaram Pharma Packtech Ltd's stock price is Rs. 24.05, down 2.99%, marking a new 52-week low and a year-to-date decline of 45.83%. The stock has underperformed its sector and the broader market, with a significant drop in investor participation.
Bandaram Pharma Packtech Hits New 52-Week Low at Rs. 24
Bandaram Pharma Packtech has hit a new 52-week low at Rs. 24, reflecting significant challenges for the microcap healthcare services firm. Over the past year, the company has experienced a steep decline of 52.90%, with recent quarterly results showing a 28.76% drop in net sales.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
